The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Completed · Not applicable

Conditions studied: Multiple Sclerosis

In brief

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Key facts

Study ID

NCT03480854

Run by

Dartmouth-Hitchcock Medical Center

People needed

694

Starts

2017-07-01

Expected to finish

2020-12-31

Last updated by the study team

2021-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.

You may not qualify if…

• Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.

Where it is running

• Neurology Associates of Greater Orlando — Maitland, Florida, United States
• Massachusetts General Hospital Multiple Sclerosis Center — Boston, Massachusetts, United States
• Concord Hospital — Concord, New Hampshire, United States
• University of Vermont Multiple Sclerosis Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.